Tempus AI (NASDAQ:TEM) Stock Price Down 4.7%

Tempus AI, Inc. (NASDAQ:TEM) fell 4.7% on Tuesday . The stock traded as low as $40.44 and last traded at $40.96. 143,726 shares changed hands during trading, a decline of 90% from the average session volume of 1,471,897 shares. The stock had previously closed at $42.98.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on TEM shares. William Blair began coverage on Tempus AI in a research report on Tuesday, July 9th. They issued an “outperform” rating on the stock. JPMorgan Chase & Co. began coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued an “overweight” rating and a $42.00 target price for the company. Stifel Nicolaus started coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $45.00 price objective for the company. Needham & Company LLC started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a “buy” rating and a $47.00 target price for the company. Finally, Loop Capital assumed coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a “buy” rating and a $48.00 target price for the company. Nine equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Tempus AI presently has a consensus rating of “Buy” and an average price target of $45.63.

Tempus AI Price Performance

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.